Bio-IT World 2014's Inaugural Data Security conference explores these challenges, the security levels necessary for different biological research data sources, tradeoffs of collaboration vs. privacy and processes and mechanisms that prevent data misuse and identify threat risks for both cloud-based systems and traditional computing.
- Sustaining collaborations in secure environments
- Securing the cloud for healthcare
- Ensuring genomic privacy and security
- Company security strategies.
Confirmed speakers include:
- R. Mark Adams, Ph.D., Good Start Genetics
- David Altshuler, M.D., Ph.D., Broad Institute of Harvard; MIT
- Toby Bloom, Ph.D., New York Genome Center
- Andrew Boudreau, Oracle Health Sciences
- Michael Braxenthaler, Ph.D., F. Hoffmann-La Roche; tranSMART Foundation
- Nitesh Chawla, Ph.D., University of Notre Dame
- Philip Groth, Ph.D., Bayer HealthCare Pharmaceuticals
- Michelle Munson, Aspera
- Niall O'Connor, GenoSpace
- Andrew Porter, Merck
- Jon Reich, Novartis/HGP Asia
- John Sabey, Sabey Data Center Properties
- Charles Schmitt, Ph.D., University of North Carolina at Chapel Hill
- William Telford, Sanofi R&D
- Stuart Young, Annai Systems
Writers and editors are invited to attend. To request a press pass or arrange an interview with a speaker, email Lisa Scimemi: email@example.com.
For additional information and to register, visit www.bio-itworldexpo.com/
About the Bio-IT World Conference & Expo (www.bio-itworldexpo.com)
The 2014 Bio-IT World Conference & Expo plans to unite 2,500+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 30+ countries. The Expo provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.
Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. The 2014 program will feature compelling talks from industry and academia on new trends in data generation, knowledge management, and information technology in life sciences and drug development, including best practice case studies and joint partner presentations relevant to the technologies, research, and regulatory issues of life science, pharmaceutical, clinical and IT professionals.
Spanning three days, the meeting includes 13 parallel conference tracks and 16 pre-conference workshops.
About Cambridge Healthtech Institute (www.chicorporate.com)
Cambridge Healthtech Institute (CHI), founded in 1992, is the industry leader in providing superior quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.